1,057
Views
21
CrossRef citations to date
0
Altmetric
Original Contributions

Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System

Pages 281-289 | Received 29 Sep 2017, Accepted 29 Sep 2017, Published online: 03 Jan 2018

References

  • Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose Deaths — United States, 2010–2015. MMWR Morb Mortal Wkly Rpt. 2016;65(5051):1445–52. doi:10.15585/mmwr.mm655051e1. PMID: 28033313.
  • Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The opioid epidemic in the United States. Emerg Med Clin North Am. 2016;34(2):e1–23. doi:10.1016/j.emc.2015.11.002. PMID: 27133253.
  • Hoffman JR, Schriger DL, Luo JS. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med. 1991;20(3):246–52. doi:10.1016/S0196-0644(05)80933-3. PMID: 1996818.
  • Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction (Abingdon, England). 2009;104(12):2067–74. doi:10.1111/j.1360-0443.2009.02724.x. PMID: 19922572.
  • Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009;13(4):512–5. doi:10.1080/10903120903144866. PMID: 19731165.
  • Weiner SG, Mitchell PM, Temin ES, Langlois BK, Dyer KS. Use of Intranasal Naloxone by basic life support providers. Prehosp Emerg Care. 2017;21(3):322–326. doi:10.1080/10903127.2017.1282562.
  • Faul M, Dailey MW, Sugerman DE, Sasser SM, Levy B, Paulozzi LJ. Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities. Am J Publ Health. 2015;105(Suppl 3):e26–32. doi:10.2105/AJPH.2014.302520. PMID: 25905856.
  • Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing Naloxone to Laypersons — United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631–5. PMID: 26086633.
  • Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15(3):320–4. doi:10.3109/10903127.2011.569854. PMID: 21612385.
  • Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of Naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016;20(5):566–9. doi:10.3109/10903127.2016.1142626. PMID: 27018626.
  • Merchant RC, Schwartzapfel BL, Wolf FA, Li W, Carlson L, Rich JD. Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997–2002. Subst Use Misuse. 2006;41(9):1209–26. doi:10.1080/10826080600751898.
  • Lindstrom HA, Clemency BM, Snyder R, Consiglio JD, May PR, Moscati RM. Prehospital Naloxone administration as a public health surveillance tool: a retrospective validation study. Prehosp Disast Med. 2015;30(4):385–9. doi:10.1017/S1049023X15004793. PMID: 26061280.
  • Knowlton A, Weir BW, Hazzard F, et al. EMS runs for suspected opioid overdose: implications for surveillance and prevention. Prehosp Emerg Care. 2013;17(3):317–29. doi:10.3109/10903127.2013.792888. PMID: 23734988.
  • Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14(7):616–23. doi:10.1111/j.1553-2712.2007.tb01846.x. PMID: 17554010.
  • Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction (Abingdon, England). 2006;101(12):1797–804. doi:10.1111/j.1360-0443.2006.01636.x. PMID: 17156179.
  • City of Cleveland Department of Public Safety Protocols. 2015. Available from: http://cecoms.cuyahogacounty.us/pdf/2015_Cleveland_Department_of_%20Public_Safety_Protocols.pdf.
  • Cleveland Clinic Regional Hospitals EMS Protocols. 2017. Available from: http://cecoms.cuyahogacounty.us/pdf/ClevelandClinicEMSProtocols.pdf.
  • Sumner SA, Mercado-Crespo MC, Spelke MB, et al. Use of Naloxone by emergency medical services during opioid Drug overdose resuscitation efforts. Prehosp Emerg Care. 2016;20(2):220–5. doi:10.3109/10903127.2015.1076096. PMID: 26383533.
  • Saybolt MD, Alter SM, Dos Santos F, et al. Naloxone in cardiac arrest with suspected opioid overdoses. Resuscitation. 2010;81(1):42–6. doi:10.1016/j.resuscitation.2009.09.016. PMID: 19913979.
  • Faul M, Lurie P, Kinsman JM, Dailey MW, Crabaugh C, Sasser SM. Multiple Naloxone administrations among emergency medical service providers is increasing. Prehosp Emerg Care. 2017;21(4):411–9. doi:10.1080/10903127.2017.1315203. PMID: 28481656.
  • Klebacher R, Harris MI, Ariyaprakai N, et al. Incidence of Naloxone redosing in the age of the new opioid epidemic. Prehosp Emerg Care. 2017:1–6. doi:10.1080/10903127.2017.1335818. PMID: 28686547. [Epub ahead of print]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.